Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Leuk Res. 2012 Mar 2;36(5):581–587. doi: 10.1016/j.leukres.2012.02.001

Fig 1.

Fig 1

Peptide Array Epitope Mapping. Overlapping peptides were tested for seroreactivity against LGL leukemia and normal donor sera (Peptide vs. Serum Group). The signal strength of the sera was interpreted as reactivity. Neg Ctl: duck hepatitis B virus core peptide. Pos Ctl: Anti-IgG1. ρ: probability, χ: mean value, σ: standard deviation.